AstraZeneca CTLA-4 Inhibitor Imjudo (Finally) Wins FDA Approval

Pharma To Carve HCC Niche On Survival Data

 
• By Alaric DeArment
  
AstraZeneca announced the approval of Imjudo, combined with Imfinzi, in HCC • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip